Driver safety in patients with primary brain tumors

被引:4
|
作者
Estevis, Eduardo [1 ]
Noll, Kyle R. [2 ]
Bradshaw, Mariana E. [2 ]
Wefel, Jeffrey S. [2 ,3 ]
机构
[1] DHR Hlth, Neurosci Inst, Edinburg, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, 1515 Holcombe Blvd,Unit 431, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
brain tumor; cancer; driving; neuropsychological function; DRIVING PERFORMANCE; OLDER DRIVERS; DEMENTIA; INVENTORY; SIMULATOR; VALIDITY; DEFICITS; IMPACT; GLIOMA; ADULTS;
D O I
10.1093/nop/npz014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. Operating a motor vehicle involves multiple cognitive and sensorimotor faculties. Neurological conditions pose driving risk, but this has not been examined in patients with primary brain tumors. Methods. Sixty-four patients with primary brain tumors (32 left hemisphere; 69% glioblastoma) completed the Cognitive Behavioral Driver's Inventory (CBDI). A subset also completed broader cognitive testing. Patient characteristics, CBDI measures, and broader neuropsychological test scores were compared between Passing and Nonpassing groups. Follow-up logistic regression analyses identified patient characteristics and CBDI measures predictive of Pass/Nonpass outcome. Point-biserial correlations determined associations between neuropsychological tests and CBDI outcome. Results. Sixty-nine percent of patients were classified as passing the CBDI. Nonpassing patients were older and more likely to have WHO grade IV and temporal lobe tumors. Age was the most salient predictor of CBDI performance. CBDI measures of speeded visual search and set-shifting, speeded response inhibition, vigilance and freedom from distractibility, and basic visual scanning speed were predictive of Pass/Nonpass outcome. Neuropsychological tests of memory in particular, but also speeded visual scanning and discrimination, executive function, basic visual attention, visuoconstruction, and manual dexterity (dominant hand), were associated with CBDI outcome. Conclusions. A sizeable proportion of patients with primary brain tumors appear at risk of driving difficulty, particularly those with higher-grade tumors and of older age. Memory, visual attention, and executive difficulties appear to contribute most to driving safety risk as determined by the CBDI. These results highlight the importance of driving safety screening in this population.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 50 条
  • [21] PRIMARY BRAIN TUMORS IN PATIENTS OVER AGE 60
    RUPP, C
    RIGGS, HE
    HOGAN, HW
    MOULTON, JAL
    NEUROLOGY, 1953, 3 (08) : 586 - 590
  • [22] BODY IMAGE DISTURBANCE IN PATIENTS WITH PRIMARY BRAIN TUMORS
    Rowe, Lindsay
    Vera, Elizabeth
    Acquaye, Alvina
    Crandon, Sonja
    Ruiz, Maria Fletcher
    Aboud, Orwa
    Boris, Lisa
    Brown, Miranda
    Garren, Nancy
    Ji, Ming
    Levine, Jason
    Mackey, Megan
    Mathan, Peter
    Romo, Carlos
    Reyes, Jennifer
    Siegel, Christine
    Smart, DeeDee
    Wu, Jing
    Gilbert, Mark
    Camphausen, Kevin
    Mendoza, Tito
    Armstrong, Terri
    NEURO-ONCOLOGY, 2018, 20 : 215 - 215
  • [23] Psychosocial and neuropsychiatric aspects of patients with primary brain tumors
    Weitzner, MA
    CANCER INVESTIGATION, 1999, 17 (04) : 285 - 291
  • [24] Chemopredictive assay for patients with primary brain tumors.
    Claudio, Pier Paolo
    Valluri, Jagan
    Mathis, Sarah E.
    Alberico, Anthony
    Alberico, Thomas
    Denvir, James
    Kimmey, Gerrit A.
    Mogul, Mark Jeffrey
    Sehgal, Rajesh
    Chowdhary, Aneel A.
    Mozayen, Mohammad
    Tirona, Maria R. B. Tria
    Matt, Laurie Beth
    Oakley, Gerald
    Denning, Krista L.
    Dougherty, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [25] Epileptic type manifestation in patients with primary brain tumors
    Ulitin, A.
    Agzamov, I.
    Agzamov, M.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 216 - 216
  • [26] Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis
    Lin, Richard J.
    Green, David L.
    Shah, Gunjan L.
    ONCOLOGIST, 2018, 23 (04): : 468 - 473
  • [27] DISTRESS AND QUALITY OF LIFE IN PATIENTS WITH PRIMARY BRAIN TUMORS
    Porensky, Emily
    Cavaliere, Robert
    Newton, Herbert
    NEURO-ONCOLOGY, 2013, 15 : 230 - 231
  • [28] Lacosamide in the Management of Patients with Malignant Primary Brain Tumors
    Schneck, Michael
    Agha, Caroline
    Hayward, Dustin
    Baldwin, Maria
    Asconape, Jorge
    Prabhu, Vikram C.
    NEUROLOGY, 2011, 76 (09) : A99 - A99
  • [29] Development of a Symptom Index for Patients with Primary Brain Tumors
    Lai, Jin-Shei
    Jensen, Sally E.
    Beaumont, Jennifer L.
    Abernethy, Amy P.
    Jacobsen, Paul B.
    Syrjala, Karen
    Raizer, Jeffrey J.
    Cella, David
    VALUE IN HEALTH, 2014, 17 (01) : 62 - 69
  • [30] Impaired fMRI activation in patients with primary brain tumors
    Jiang, Zhen
    Krainik, Alexandre
    David, Olivier
    Salon, Caroline
    Tropres, Irene
    Hoffmann, Dominique
    Pannetier, Nicolas
    Barbier, Emmanuel L.
    Bombin, Eduardo Ramos
    Warnking, Jan
    Pasteris, Caroline
    Chabardes, Stefan
    Berger, Francois
    Grand, Sylvie
    Segebarth, Christoph
    Gay, Emmanuel
    Le Bas, Jean-Francois
    NEUROIMAGE, 2010, 52 (02) : 538 - 548